As big blockbusters such as Pfizer’s Lipitor go off patent, the industry is about to lose tens of billions of dollars in revenues to generics manufacturers.
降血脂类明星产品,辉瑞药业的利普妥专利过期之后, 非专利类制造商将抢走该公司预计高达数百亿美元的收入.
As big blockbusters such as Pfizer’s Lipitor go off patent, the industry is about to lose tens of billions of dollars in revenues to generics manufacturers.
降血脂类明星产品,辉瑞药业的利普妥专利过期之后, 非专利类制造商将抢走该公司预计高达数百亿美元的收入.
应用推荐